IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $886,198 | +16.8% | 19,537 | +5.6% | 0.11% | +7.7% |
Q2 2023 | $758,973 | -65.8% | 18,498 | -69.1% | 0.10% | -46.7% |
Q2 2022 | $2,216,000 | -25.3% | 59,865 | -25.2% | 0.20% | -23.5% |
Q1 2022 | $2,966,000 | +44.0% | 80,070 | +18.3% | 0.26% | +62.4% |
Q4 2021 | $2,060,000 | -63.6% | 67,697 | -52.3% | 0.16% | -58.0% |
Q2 2021 | $5,661,000 | -10.6% | 141,925 | +26.7% | 0.37% | -12.6% |
Q4 2020 | $6,335,000 | +9.8% | 112,045 | -7.8% | 0.43% | +12.3% |
Q3 2020 | $5,769,000 | -15.9% | 121,582 | +4.5% | 0.38% | -18.4% |
Q2 2020 | $6,857,000 | -75.3% | 116,300 | -66.0% | 0.47% | -70.2% |
Q1 2019 | $27,744,000 | +31.2% | 341,800 | -12.7% | 1.57% | +32.7% |
Q4 2018 | $21,154,000 | +4.8% | 391,300 | -0.0% | 1.18% | +41.1% |
Q3 2018 | $20,185,000 | +23.8% | 391,337 | +0.0% | 0.84% | +35.4% |
Q2 2018 | $16,305,000 | +2.4% | 391,300 | +8.3% | 0.62% | +15.3% |
Q1 2018 | $15,922,000 | -22.1% | 361,200 | -11.1% | 0.54% | -9.4% |
Q4 2017 | $20,440,000 | -5.1% | 406,361 | -4.4% | 0.59% | -16.7% |
Q3 2017 | $21,543,000 | – | 424,910 | – | 0.71% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |